TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06502626

Intervention type: OTHER
Group type: OTHER
Intervention: Regular training
Description: performed their routine programs

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sprint Interval Training
Description: Sprint interval training will be given for 4 weeks. Each week consisted of three training sessions, separated by at least one resting day. Participants will complete a 15-minutes warm up before training session. The Sprint interval training group consisted of 30 s sprints at near maximal effort, with three minutes of rest between each sprint. The training intensity of Sprint interval training sessions was evaluated subjectively during sessions. During the first week, the Sprint interval training group performed five sprints per session. The number of sprints then increased gradually, until a total of 10 sprints per session. When the number of sprints reached seven, subjects were given six minutes of rest midway through the training session
Study: NCT05484336

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage containing 6g spirulina
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 6g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage containing 6g spirulina
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 6g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage containing 8g spirulina
Description: Thirteen healthy, with BMI between 18 and 29.9 kg/m2 (male: 3, female:10) after 10-14h fast, consumed 50g glucose and 8g spirulina diluted in 250ml, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120min.
Study: NCT05278611

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EP-9001A
Description: The initial dose of the study was set as 1 mg, and the doses were escalated sequentially in the order of 1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg, and 25 mg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study: NCT05153252

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Morning Exercise
Description: Morning Exercise will be instructed to perform 2000 kcal/wk of moderate to vigorous intensity aerobic exercise between the hours of 6 and 10 AM.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Evening Exercise
Description: PM will be instructed to perform 2000 kcal/wk of moderate to vigorous intensity aerobic exercise between the hours of 3 and 7 PM.
Study: NCT04343027

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Review
Description: Physicians will review patient-reported outcome measurements with their patients during office visits.
Study: NCT03718650

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pimonidazole
Description: Patients will take a single dose of 0.5 g/m\^2 (approximately 13 mg/kg) of oral pimonidazole HCI 16 to 24 hours prior to surgery.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Resection
Description: Patients will undergo Pancreaticoduodenectomy or Whipple procedure, which involves the resection of the pancreatic head, duodenum, gallbladder, and a portion of the stomach, 16 to 24 hours after consuming oral pimonidazole.
Study: NCT06421298

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tafolecimab
Description: 450mg Q4W ≤6cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200mg Q3W ≤2years

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: 130mg/m² Q3W 4-6cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: 75mg/m² Q3W 4-6cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: 1250mg/m² Q3W 4-6cycles
Study: NCT06381557

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zhengyuan Capsules
Description: Zhengyuan capsules, 4 capsules at a time, 3 times per day;

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo contains 5%-10% Zhengyuan Capsule total mixed powder
Description: Zhengyuan capsules simulator（Placebo contains 5%-10% Zhengyuan Capsule total mixed powder）, 4 capsules at a time, 3 times per day;
Study: NCT05163392

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Silverlon
Description: SIlver-plated biopatch

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Tegaderm without biopatch
Study: NCT06197464

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: psychoeducation on emotional regulation and distraction strategy
Description: The experimenter gives the subject psychoeducation about emotional regulation and distraction strategy with the help of a conversation and a presentation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Using the FLOAT app on a virtual reality device
Description: The subject should wear the VR device, and use the FLOAT application.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: psychoeducation on emotional regulation and distraction strategy + Application
Description: psychoeducation on emotional regulation and distraction strategy + Application
Study: NCT04911764

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Three-min Step Test and Exercise desaturation detection in COPD
Description: For this research, 2 visits will be scheduled (V1 and V2) for each patient. During V1, after collecting the filled and signed consent form from the patient, anthropometric measurements and pulmonary function assessment will be performed before the realization of a maximal graded test. This inclusion visit will be carried out as part of an inclusion within a respiratory rehabilitation program. During V2, each patient will randomly perform a 6-minute walking test and a 3-minute step test, in similar standard conditions. A 30-minute resting period will be allowed between the two field tests. During the realization of the tests, cardio-respiratory adaptations will be monitored throughout both tests with portable gas analyzer and pulsed oxymetry system.
Study: NCT06146868

Intervention type: OTHER
Intervention: Doing questionnaire
Description: Participants will provide their opinions in a questionnaire

Intervention type: OTHER
Intervention: Doing questionnaire
Description: Participants will provide their opinions in a questionnaire

Intervention type: OTHER
Intervention: Doing questionnaire
Description: Participants will provide their opinions in a questionnaire

Intervention type: OTHER
Intervention: Doing questionnaire
Description: Participants will provide their opinions in a questionnaire
Study: NCT05545202

Intervention type: OTHER
Group type: OTHER
Intervention: Pentaisomaltose
Description: Each subject will receive 1 or 2 bags with cryopreserved cells according to randomization group.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pentaisomaltose
Description: Each subject will receive 1 or 2 bags with cryopreserved cells according to randomization group.
Study: NCT04167215

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: superior gluteal artery flap and lumbar artery falp
Description: Doppler ultrasound will be used to confirm location of the superior gluteal artery perforators or lumbar perforators . Flaps will be designed to allow deepithelialization and dissection . After complete sketolization of the flap it will be analyzed for viability and trimmed to achieve the desired bulk.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: superior gluteal artery flap and lumbar artery falp
Description: Doppler ultrasound will be used to confirm location of the superior gluteal artery perforators or lumbar perforators . Flaps will be designed to allow deepithelialization and dissection . After complete sketolization of the flap it will be analyzed for viability and trimmed to achieve the desired bulk.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: The gluteal pocket
Description: pocket will be created by undermining in a plane just superficial to the gluteal muscle from the lower body lift line inferiorly extending to within 5 cm of the inferior gluteal crease. should extend only over the medial half of the buttock.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: The gluteal pocket
Description: pocket will be created by undermining in a plane just superficial to the gluteal muscle from the lower body lift line inferiorly extending to within 5 cm of the inferior gluteal crease. should extend only over the medial half of the buttock.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: infragluteal dermal lifiting flap
Description: dermal flap will be performed for lifting the ptotic buttocks with ill-defined infragluteal fold. This deepithelialized dermal flap allows for the creation of a well-defined stable infragluteal fold through an incision of the infragluteal fold and exposure of ischial tuberosity and anchor it to the ischial tuberosity.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: infragluteal dermal lifiting flap
Description: dermal flap will be performed for lifting the ptotic buttocks with ill-defined infragluteal fold. This deepithelialized dermal flap allows for the creation of a well-defined stable infragluteal fold through an incision of the infragluteal fold and exposure of ischial tuberosity and anchor it to the ischial tuberosity.
Study: NCT04095689

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Microtubule-targeting drug (inhibits microtubule depolymerization)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Programmed cell death-1 (PD-1) inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IL-12 gene therapy
Description: Adenoviral-mediated IL-12
Study: NCT04904809

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Perclose ProGlide SMC System and/or Perclose ProStyle SMCR System
Description: The Perclose ProGlide SMC and Perclose ProStyle SMCR in this study will be used for multiple access site closures in a single vein in the ablation procedure.
Study: NCT05157347

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robot-assisted Training
Description: The gait training in this study uses an exoskeletal wearable robot (Product name: ANGEL LEGS M20, Angel robotics, Co., Ltd.) consisting of a wearable part, a hip or knee joint gear providing the auxiliary force, and a controller backpack. This product is a powered orthopedic device for gait rehabilitation and treatment such as the lower limb muscle reconstruction and joint motion recovery in patients or handicapped individuals. The product consists of a power part, a controller part and a gear part, while the device is powered by an electric motor and the device motion induces the gait posture to support the lower limbs and allow the gait training to be performed.

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional Therapy
Description: The conventional gait rehabilitation has been performed as a 1:1 training session between the therapist and a stroke patient.
Study: NCT05505188

Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaire
Description: Self-questionnaires are completed by the patient at the time of this consultation:~* Neuropathic pain: NPSI in screening~* Anxiety/depression: HADS in screening~* Quality of life: EORTC (QLQC30 and H\&N43)~* Fatigue: MFI-20 hese self-questionnaires will be retrieved by the Clinical Research Associate (CRA) for verification.~Depending on the result of the NPSI questionnaire can be completed to better characterize neuropathic pain.~Depending on the result of the HADS, the MADRS questionnaire can be completed to quantify the degree of depression.~Individuals diagnosed with neuropathic pain or other depressive symptoms during the 6-month inclusion period will be referred to and managed by specialized practitioners. This assistance will be indicated in follow-up report
Study: NCT06182605

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: multifunctional instruments
Description: Ophthalmic retractors can be used to lift the lens during surgery to assist in lens sucking or resection; Intraoperative injection of reagent, which has the advantage of retractable, micro-incision. Ophthalmic hooks can be used to secure support capsular bags; auxiliary cleavage; polishing capsule; Viscoelastic agent is injected as needed. The front end of the membranous cataract scissor is a capsular tearing forceps, and the capsule tearing and capsule scissors can be flexibly switched. All three instruments have the functions of two or three traditional instruments, which can be designed to reduce the number of times the instruments enter and exit the incision during surgery, improve surgical efficiency,

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: traditional instruments
Description: traditional Cataract-assisted instruments for cataract operation.Puncture knives, microscissors, microscopic forceps, nucleus hooks, lens graft forceps, are used to cut the cornea, assist in removing the cloudy lens, suturing wounds.
Study: NCT05513313

Intervention type: BIOLOGICAL
Intervention: JYNNEOS
Description: smallpox vaccine

Intervention type: BIOLOGICAL
Intervention: JYNNEOS
Description: smallpox vaccine

Intervention type: BIOLOGICAL
Intervention: JYNNEOS
Description: smallpox vaccine
Study: NCT05835921

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Virtual Reality
Description: Both groups will receive a Virtual Reality Park experience, which is an empty park with no avatars. Only the experimental group will have a Virtual Reality Avatar experience, where they will see an avatar resembling themselves in a park setting.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: Both groups will receive a Virtual Reality Park experience, which is an empty park with no avatars. Only the experimental group will have a Virtual Reality Avatar experience, where they will see an avatar resembling themselves in a park setting.
Study: NCT06008483

Intervention type: DRUG
Group type: OTHER
Intervention: 153-Sm-DOTMP (Samarium-153-DOTMP)
Description: This is an open-label, unblinded, multi-center, dose-finding study of 153Sm-DOTMP (CycloSam®) to identify the MTD of 153Sm- DOTMP, given as a tandemly administered pair of doses to subjects with solid tumors visible on bone scan.

Intervention type: DRUG
Group type: OTHER
Intervention: 153-Sm-DOTMP (Samarium-153-DOTMP)
Description: This is an open-label, unblinded, multi-center, dose-finding study of 153Sm-DOTMP (CycloSam®) to identify the MTD of 153Sm- DOTMP, given as a tandemly administered pair of doses to subjects with solid tumors visible on bone scan.

Intervention type: DRUG
Group type: OTHER
Intervention: 153-Sm-DOTMP (Samarium-153-DOTMP)
Description: This is an open-label, unblinded, multi-center, dose-finding study of 153Sm-DOTMP (CycloSam®) to identify the MTD of 153Sm- DOTMP, given as a tandemly administered pair of doses to subjects with solid tumors visible on bone scan.

Intervention type: DRUG
Group type: OTHER
Intervention: 153-Sm-DOTMP (Samarium-153-DOTMP)
Description: This is an open-label, unblinded, multi-center, dose-finding study of 153Sm-DOTMP (CycloSam®) to identify the MTD of 153Sm- DOTMP, given as a tandemly administered pair of doses to subjects with solid tumors visible on bone scan.
Study: NCT06258655

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Close Collaboration with Parents
Description: The Close Collaboration with Parents intervention is an educational program for the neonatal staff to improve their skills to collaborate with parents and provide support to parenting during an infant's hospitalization. First, experienced nurses and doctors from the units will undergo a 14-day to become unit mentors. Then these unit mentors will train other members of staff. The training of the units is based on bedside practices, a reflection of the practices, and the application of the knowledge in everyday work. Theoretical learning, preceding clinical bedside mentoring, will occur through an e-learning module. Staff members will spend about 4 working days in training alongside their routine work. The unit mentors will function as facilitators for the staff, and they have dedicated time for this. The content of the bedside practices is guided by a manual. The training team will provide frequent remote and contact support for the implementation.
Study: NCT06350292

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SLEEP: COPE
Description: Standard CBT-I techniques along with modules targeting noncompliance in children with ODD and their parents.
Study: NCT05236985

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin bolus or oxytocin infusion
Description: On the day of surgery, the patients will be randomized to either bolus or infusion administration of oxytocin.~On the day of the procedure, periprocedural data and patient satisfaction (single question) will be recorded.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin bolus or oxytocin infusion
Description: On the day of surgery, the patients will be randomized to either bolus or infusion administration of oxytocin.~On the day of the procedure, periprocedural data and patient satisfaction (single question) will be recorded.
Study: NCT04902521

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation
Description: Repetitive transcranial magnetic stimulation (TMS) is a safe non-invasive technique that stimulates the brain using repetitive magnetic pulses to enhance neuroplasticity. TMS has been shown to produce lasting modulation of cortical activity and improve clinical symptoms of children with neurodevelopmental disorders including CP

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Transcranial Magnetic stimulation
Description: Sham Transcranial Magnetic stimulation will be given to the control group. During the Sham procedure patients will sit near the TMS but will not receive any magnetic pulses.
Study: NCT04460586

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omadacycline Injection [Nuzyra]
Description: Participants will receive single dose of omadacycline 100mg IV followed by a 1-week washout and receipt of single dose omadacycline 300 mg PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omadacycline Oral Tablet [Nuzyra]
Description: Participants will receive single dose of omadacycline 100mg IV followed by a 1-week washout and receipt of single dose omadacycline 300 mg PO.
Study: NCT05611047

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical assessment
Description: MS history and MS treatments and Expanded Disability Status Scale (EDSS) score will be recorded

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinical assessment
Description: MS history and MS treatments and Expanded Disability Status Scale (EDSS) score will be recorded

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Classical cognitive evaluation of several domains:
Description: Information processing speed (IPS) Working memory (WM) Executive functions (EF) Episodic memory (EM) Premorbid intelligence quotient (IQ) Multidomain or complex task

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Classical cognitive evaluation of several domains:
Description: Information processing speed (IPS) Working memory (WM) Executive functions (EF) Episodic memory (EM) Premorbid intelligence quotient (IQ) Multidomain or complex task

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ecological evaluation
Description: Virtual reality task : Urban DailyCog©

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ecological evaluation
Description: Virtual reality task : Urban DailyCog©

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patent reported outcomes (PRO's)
Description: Patent reported outcomes (PRO's) : Beck Depression Inventory (BDI), European Quality of Life-5 Dimensions (EQ-5D-5L) for Health-Related Quality of Life (HRQOL), Multiple Sclerosis Impact Scale-29 Items (MSIS-29), French version of the Modified Fatigue Impact Scale (EMISEP) and State trait anxiety inventory (STAI).~Subjective cognitive deficits: Perceived Deficits Questionnaire (PDQ) and Cognitive Activities Questionnaire (DCAQ)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patent reported outcomes (PRO's)
Description: Patent reported outcomes (PRO's) : Beck Depression Inventory (BDI), European Quality of Life-5 Dimensions (EQ-5D-5L) for Health-Related Quality of Life (HRQOL), Multiple Sclerosis Impact Scale-29 Items (MSIS-29), French version of the Modified Fatigue Impact Scale (EMISEP) and State trait anxiety inventory (STAI).~Subjective cognitive deficits: Perceived Deficits Questionnaire (PDQ) and Cognitive Activities Questionnaire (DCAQ)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation : active procedure
Description: The Cognitive rehabilitation (CR) consists of weekly 45 minutes online individual session with the unblinded Speech Therapist.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Telerehabilitation : comparator procedure
Description: Once per week over a 12-week period completed by daily online exercises performed by the patient 4 days a week.
Study: NCT05118815

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Slim abutment
Description: Use a narrower abutment to see if they present a better biological seal.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard abutment
Description: Use a standard abutment
Study: NCT04940650

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: exercise testing
Description: To define the strenuous physical exercise in this study, each participant will be asked to perform two hours of high intensity (HIT)-effort during the endurance exercise of at least 6 to 7 hours. Therefore all participants will have exercise testing approximately 1 week before the physical exercise to set aerobic and anaerobic gas exchange thresholds, as well as VO2max.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Echocardiography
Description: Measurements of mass, volumes and function will be obtained of both the left and right ventricles at rest enabling comparisons with cardiac MRI and traditional echo measures.
Study: NCT06486688

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Centralized Virtual SBIRT
Description: Brief interventions are delivered virtually by video or telephone by a centralized behavioral health clinician

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Centralized Virtual SBIRT
Description: Brief interventions are delivered virtually by video or telephone by a centralized behavioral health clinician
Study: NCT06169800

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MPFL repair with Biobrace augmentation
Description: MPFL repair with Biobrace augmentation
Study: NCT05589207

Intervention type: DIAGNOSTIC_TEST
Intervention: Vascular wall invaded
Description: Inferior vena cava vascular wall is invaded according to pathologic examination on the postoperative tumor thrombus/ vascular wall specimen.